Efficacy of Zonisamide in the treatment of children with refractory epilepsy

Efficacy of Zonisamide in the treatment of children with refractory epilepsy coming to Mofid children hospital

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT2012091210508N2

Enrollment

Registered

2012-10-09

Start date

2011-11-01

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

interactable epilepsy. Episodic and paroxysmal disorders

Interventions

Children with seizures which admitted to Mofid children hospital and despite taking two or three anti-seizure medication, have uncontrolled seizure,and do not have neurodegenerative diseases, has been

Treatment - Drugs

Eligibility

Sex/Gender

All

Age

1 Years to 18 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: children one to eighteen years, having resistant epilepsy; referred to Mofid Children's Hospital Exclusion criteria: children with neurodegenerative diseases

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Seizure. Timepoint: 1 and 6 months after drug starting. Method of measurement: Interview.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Mohammad Kazem Bakhshandeh Bali

Pediatric neurology research center

Dr.MK.Bakhshandehbali@sbmu.ac.ir+212 2259625

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026